PACAP38 and Radiation Together Fight Cancer Growth
Author Information
Author(s): Wu Ran, Cao Chun-Xiang, Cao Lu, Su Jun, Liao Ke-Man, Li Huan, Zhu Qian, Li Shu-Yan, Li Min, Chen Jia-Yi
Primary Institution: Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Hypothesis
This study aimed to investigate the impact of PACAP38, both independently and in combination with irradiation, on glioma and breast cancer cells.
Conclusion
PACAP38 synergizes with irradiation to suppress the proliferation of multiple cancer cells via regulating SOX6/Wnt/β-catenin signaling.
Supporting Evidence
- PACAP38 effectively suppresses the proliferation of glioma and breast cancer cells.
- The combination of PACAP38 and irradiation shows a greater effect than either treatment alone.
- SOX6 expression is upregulated by PACAP38, which inhibits the Wnt-β-catenin signaling pathway.
Takeaway
PACAP38 is a special protein that helps stop cancer cells from growing, especially when used with radiation treatment.
Methodology
The study used in vitro and in vivo experiments, including cell counting kit-8, clonogenic formation, Edu assays, and RNA sequencing to analyze the effects of PACAP38 on cancer cells.
Limitations
The study does not address the long-term effects of PACAP38 treatment or its potential side effects in humans.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website